Molnupiravir is an antiviral medication used to treat mild to moderate COVID-19. It works by interfering with viral replication, leading to the production of defective viral particles. Molnupiravir is effective in reducing viral load in infected patients. Common side effects may include nausea and diarrhea, but these usually resolve over time. In summary, Molnupiravir is crucial for managing COVID-19 infections.
Molnupiravir introduces errors into the viral RNA during replication, leading to the production of non-infectious viral particles.





